INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

75,408 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
RG
Rottmann Scott GlennPresident
RGPRESOURCES CONNECTION, INC.
Tax withholding
F$20K
4,739 sh
Aug 10, 2026Aug 14, 2026
Page 620 of 1886
← PrevNext →
traded Aug 10, 2026
+4d
SEC Form 4

Evidence

15
MD
Malhotra DeepakDirector
TMRCDyTb, LLC
Disposition to issuer
D—
244.8K sh
Aug 7, 2026Aug 14, 2026
traded Aug 7, 2026
+7dSEC Form 4

Evidence

15
BH
Blumenthal Neil HarrisDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise
M$766K
200.0K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

15
MG
Marchese Anthony G.Director
TMRCDyTb, LLC
Disposition to issuer
D—
5.17M sh
Aug 7, 2026Aug 14, 2026
traded Aug 7, 2026
+7dSEC Form 4

Evidence

14
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$623K
2,765 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

14
JJ
Jergensen JoshuaPresident & COO
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$161K
3,625 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

14
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$684K
3,080 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

14
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$407K
1,800 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

14
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$379K
1,698 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

14
BS
Blake SarahSVP, Chief Accounting Officer
VGVenture Global, Inc.
Option exercise
M$1.55M
1.00M sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

14
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$651K
2,943 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

14
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$350K
1,568 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

14
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$582K
2,595 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

13
KC
Kim John C.Director
OWLTOwlet, Inc.
Grant or award
A—
26.8K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

13
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Option exercise
M—
5,781 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

13
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$38K
5,000 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

13
MF
Mottola FrankSVP, Chief Tech. Ops. Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Option exercise
M—
1,650 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

13
RS
Ravella SatishChief Accounting Officer
ZETAZeta Global Holdings Corp.
Option exercise
M—
6,250 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

13
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Option exercise
M—
750 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

13
MA
Mancini Christopher AndrewSVP OF PROF SALES & STORE OPS
ORLYO REILLY AUTOMOTIVE INC
Option exercise
M—
3,000 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$30K
4,000 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

13
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Option exercise
M—
7,031 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

13
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Option exercise
M—
7,031 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

13
VM
Veness Adam MSVP, General Counsel and Sec.
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise
M—
15.0K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

13
BH
Brodie Bradley HarrisSVP, General Counsel,Secretary
DOUGDouglas Elliman Inc.
Tax withholding
F$49K
24.6K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

13
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Option exercise
M—
109.2K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

12
SM
Stevenson MatthewDirector, President and CEO
HLLYHolley Inc.
Tax withholding
F$180K
56.8K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

12
HM
Howell Stephen Mitchell Jr.COO
RIOTRiot Platforms, Inc.
Gift
G—
21.2K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

12
LP
Loop PaulaDirector
FSLYFastly, Inc.
Open-market sale · 10b5-1 plan
SELL$220K
7,332 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

12
SC
Sciarra Paul CahillDirector
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$498K
62.5K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

12
RS
Ravella SatishChief Accounting Officer
ZETAZeta Global Holdings Corp.
Option exercise
M$79K
6,250 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

12
RS
Ravella SatishChief Accounting Officer
ZETAZeta Global Holdings Corp.
Tax withholding
F$124K
4,329 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

11
VM
Veness Adam MSVP, General Counsel and Sec.
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise
M$273K
15.0K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$214K
972 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$170K
757 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$227K
1,022 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$131K
600 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

10
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M$855K
16.2K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
DB
Derakhshan BehradChief Business Officer
EWTXEdgewise Therapeutics, Inc.
Grant or award
A—
50.0K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

9
NM
Nofi MichaelChief Financial Officer
EWTXEdgewise Therapeutics, Inc.
Grant or award
A—
24.4K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence